Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor von Segura, Miguel F, Hanniford, Douglas, Menendez, Silvia, Reavie, Linsey, Zou, Xuanyi, Alvarez-Diaz, Silvia, Zakrzewski, Jan, Blochin, Elen, Rose, Amy, Bogunovic, Dusan, Polsky, David, Wei, Jianjun, Lee, Peng, Belitskaya-Levy, Ilana, Bhardwaj, Nina, Osman, Iman, Hernando, Eva

Volltext

miR-30b/30d Regulation of GalNAc Transferases Enhances Invasion and Immunosuppression during Metastasis von Gaziel-Sovran, Avital, Segura, Miguel F., Di Micco, Raffaella, Collins, Mary K., Hanniford, Douglas, Vega-Saenz de Miera, Eleazar, Rakus, John F., Dankert, John F., Shang, Shulian, Kerbel, Robert S., Bhardwaj, Nina, Shao, Yongzhao, Darvishian, Farbod, Zavadil, Jiri, Erlebacher, Adrian, Mahal, Lara K., Osman, Iman, Hernando, Eva

Volltext

Melanoma MicroRNA Signature Predicts Post-Recurrence Survival von SEGURA, Miguel F, BELITSKAYA-LEVY, Ilana, OSMAN, Iman, HERNANDO, Eva, ROSE, Amy E, ZAKRZEWSKI, Jan, GAZIEL, Avital, HANNIFORD, Douglas, DARVISHIAN, Farbod, BERMAN, Russell S, SHAPIRO, Richard L, PAVLICK, Anna C

Volltext

MicroRNA‐125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway von Koetz‐Ploch, Lisa, Hanniford, Douglas, Dolgalev, Igor, Sokolova, Elena, Zhong, Judy, Díaz‐Martínez, Marta, Bernstein, Emily, Darvishian, Farbod, Flaherty, Keith T., Chapman, Paul B., Tawbi, Hussein, Hernando, Eva

Volltext

Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis von Hanniford, Douglas, Ulloa-Morales, Alejandro, Karz, Alcida, Berzoti-Coelho, Maria Gabriela, Moubarak, Rana S., Sánchez-Sendra, Beatriz, Kloetgen, Andreas, Davalos, Veronica, Imig, Jochen, Wu, Pamela, Vasudevaraja, Varshini, Argibay, Diana, Lilja, Karin, Tabaglio, Tommaso, Monteagudo, Carlos, Guccione, Ernesto, Tsirigos, Aristotelis, Osman, Iman, Aifantis, Iannis, Hernando, Eva

Volltext

Revisiting determinants of prognosis in cutaneous melanoma von Weiss, Sarah A., Hanniford, Douglas, Hernando, Eva, Osman, Iman

Volltext

The State of Melanoma: Emergent Challenges and Opportunities von Atkins, Michael B., Curiel-Lewandrowski, Clara, Fisher, David E., Swetter, Susan M., Tsao, Hensin, Aguirre-Ghiso, Julio A., Soengas, Maria S., Weeraratna, Ashani T., Flaherty, Keith T., Herlyn, Meenhard, Sosman, Jeffrey A., Tawbi, Hussein A., Pavlick, Anna C., Cassidy, Pamela B., Chandra, Sunandana, Chapman, Paul B., Daud, Adil, Eroglu, Zeynep, Ferris, Laura K., Fox, Bernard A., Gershenwald, Jeffrey E., Gibney, Geoffrey T., Grossman, Douglas, Hanks, Brent A., Hanniford, Douglas, Hernando, Eva, Jeter, Joanne M., Johnson, Douglas B., Khleif, Samir N., Kirkwood, John M., Leachman, Sancy A., Mays, Darren, Nelson, Kelly C., Sondak, Vernon K., Sullivan, Ryan J., Merlino, Glenn

Volltext

circSamd4 represses myogenic transcriptional activity of PUR proteins von Pandey, Poonam R, Yang, Jen-Hao, Tsitsipatis, Dimitrios, Panda, Amaresh C, Noh, Ji Heon, Kim, Kyoung Mi, Munk, Rachel, Nicholson, Thomas, Hanniford, Douglas, Argibay, Diana, Yang, Xiaoling, Martindale, Jennifer L, Chang, Ming-Wen, Jones, Simon W, Hernando, Eva, Sen, Payel, De, Supriyo, Abdelmohsen, Kotb, Gorospe, Myriam

Volltext

A TGFβ-miR-182-BRCA1 axis controls the mammary differentiation hierarchy von Martinez-Ruiz, Haydeliz, Illa-Bochaca, Irineu, Omene, Coral, Hanniford, Douglas, Liu, Qi, Hernando, Eva, Barcellos-Hoff, Mary Helen

Volltext

Revisiting determinants of prognosis in cutanous melanoma von Weiss, Sarah, Hanniford, Douglas, Hernando, Eva, Osman, Iman

Volltext

BET and BRAF inhibitors act synergistically against BRAF‐mutant melanoma von Paoluzzi, Luca, Hanniford, Douglas, Sokolova, Elena, Osman, Iman, Darvishian, Farbod, Wang, Jinhua, Bradner, James E., Hernando, Eva

Volltext

Functional analysis of RPS27 mutations and expression in melanoma von Floristán, Alfredo, Morales, Leah, Hanniford, Douglas, Martinez, Carlos, Castellano‐Sanz, Elena, Dolgalev, Igor, Ulloa‐Morales, Alejandro, Vega‐Saenz de Miera, Eleazar, Moran, Una, Darvishian, Farbod, Osman, Iman, Kirchhoff, Tomas, Hernando, Eva

Volltext

Abstract PR04: Epigenetic silencing of CDR1as drives IGF2BP3-mediated melanoma invasion and metastasis von Hanniford, Douglas, Ulloa-Morales, Alejandro, Sánchez-Sendra, Beatriz, Karz, Alcida, Moubarak, Rana, Tabaglio, Tommaso, Berzoti-Coelho, Maria Gabriela, Davalos, Veronica, Wu, Pamela, Vasudevaraja, Varshini, Kloetgen, Andreas, Lilja, Karin, Imig, Jochen, Monteagudo, Carlos, Guccione, Ernesto, Tsirigos, Aristotelis, Osman, Iman, Aifantis, Iannis, Hernando, Eva

Volltext

Mutation burden as a potential prognostic marker of melanoma progression and survival von Simpson, Danny, Ferguson, Robert, Martinez, Carlos N., Kazlow, Esther, Moran, Una, Heguy, Adriana, Hanniford, Douglas, Hernando, Eva, Osman, Iman, Kirchhoff, Tomas

Volltext

Abstract 3522: BET and BRAF inhibitors act synergistically against BRAF mutant melanoma von Paoluzzi, Luca, Hanniford, Douglas, Sokolova, Elena, Osman, Iman, Darvishian, Farbod, Wang, Jinhua, Bradner, James E., Hernando, Eva

Volltext

Histology-Specific MicroRNA Alterations in Melanoma von Poliseno, Laura, Haimovic, Adele, Segura, Miguel F., Hanniford, Douglas, Christos, Paul J., Darvishian, Farbod, Wang, Jinhua, Shapiro, Richard L., Pavlick, Anna C., Berman, Russell S., Hernando, Eva, Zavadil, Jiri, Osman, Iman

Volltext

Micro RNA ‐125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway von Koetz‐Ploch, Lisa, Hanniford, Douglas, Dolgalev, Igor, Sokolova, Elena, Zhong, Judy, Díaz‐Martínez, Marta, Bernstein, Emily, Darvishian, Farbod, Flaherty, Keith T., Chapman, Paul B., Tawbi, Hussein, Hernando, Eva

Volltext

Melanoma recurrence risk stratification using Bayesian systems biology modeling von Styrmisdottir, Edda Lind, Scanlon, Patrick, Hanniford, Douglas, Eberhardt, John, Jones, Thomas, Hernando, Eva, Osman, Iman

Volltext

Preclinical testing supports combined BET and BRAF inhibition as a promising therapeutic strategy for melanoma von Paoluzzi, Luca, Hanniford, Douglas, Sokolova, Elena, Dolgalev, Igor, Heguy, Adriana, Osman, Iman, Darvishian, Farbod, Wang, Jinhua, Bradner, James E., Hernando, Eva

Volltext

Clinical relevance of SKP2 alterations in metastatic melanoma von Rose, Amy E., Wang, Guimin, Hanniford, Douglas, Monni, Stefano, Tu, Ting, Shapiro, Richard L., Berman, Russell S., Pavlick, Anna C., Pagano, Michele, Darvishian, Farbod, Mazumdar, Madhu, Hernando, Eva, Osman, Iman

Volltext